Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
- Resource Type
- Authors
- Gavin Martin; Christopher R. Polage; Catherine Rehder; Jessica Seidelman; Becky Smith; Thomas N. Denny; Ibukunoluwa C. Akinboyo; Mark J Lee; Bruce Lobaugh; Michael B. Datto; Sarah S. Lewis; Diana M. Cardona; Cameron R. Wolfe; Allan B Kirk
- Source
- Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
- Subject
- Microbiology (medical)
medicine.medical_specialty
2019-20 coronavirus outbreak
Infectious Disease Transmission, Patient-to-Professional
Coronavirus disease 2019 (COVID-19)
Epidemiology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Public health interventions
030501 epidemiology
Asymptomatic
03 medical and health sciences
COVID-19 Testing
Health care
Preoperative Care
North Carolina
Medicine
Humans
Personal protective equipment
Personal Protective Equipment
business.industry
Concise Communication
COVID-19
Surgical procedures
Infectious Diseases
Surgical Procedures, Operative
Emergency medicine
medicine.symptom
0305 other medical science
business
- Language
- English
- ISSN
- 1559-6834
0899-823X
We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was